Par Pharm., et al. v. TWi Pharm., 2014 WL 694976 (D. MD)
Feb 21, 2014OUTCOME: Judgment in favor of TWi following trial; '576 patent determined to be invalid
Represented TWi in action alleging TWi's generic version of Megace ES would infringe US Patent No. 7,101,576
